Skip to Main Content

Author Details

Frank C Marini
Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine
1990
105
49
PMIDPaper TitleJournal TitlePublished Year
37349353Development of a novel air-liquid interface airway tissue equivalent model for in vitro respiratory modeling studies.Sci Rep2023
37349353Development of a novel air-liquid interface airway tissue equivalent model for in vitro respiratory modeling studies.Sci Rep2023
35223131Bioreactor design and validation for manufacturing strategies in tissue engineering.Biodes Manuf2022
35223131Bioreactor design and validation for manufacturing strategies in tissue engineering.Biodes Manuf2022
32910082Evaluation of Host Immune Cellular and Extracellular Matrix Responses to Prolapse Mesh With and Without Tension in a Rat Model.Female Pelvic Med Reconstr Surg2021
33532340Fertility preservation for pediatric male cancer patients: illustrating contemporary and future options; a case report.Transl Androl Urol2021
32910082Evaluation of Host Immune Cellular and Extracellular Matrix Responses to Prolapse Mesh With and Without Tension in a Rat Model.Female Pelvic Med Reconstr Surg2021
33105344Polycarbonate Urethane Mesh: A New Material for Pelvic Reconstruction.Female Pelvic Med Reconstr Surg2021
33532340Fertility preservation for pediatric male cancer patients: illustrating contemporary and future options; a case report.Transl Androl Urol2021
33105344Polycarbonate Urethane Mesh: A New Material for Pelvic Reconstruction.Female Pelvic Med Reconstr Surg2021
32224870Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10.Cancers (Basel)2020
32001204Dynamic Changes in Erectile Function and Histological Architecture After Intracorporal Injection of Human Placental Stem Cells in a Pelvic Neurovascular Injury Rat Model.J Sex Med2020
32224870Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10.Cancers (Basel)2020
32806623Imaging of Fibroblast Activation Protein Alpha Expression in a Preclinical Mouse Model of Glioma Using Positron Emission Tomography.Molecules2020
32001204Dynamic Changes in Erectile Function and Histological Architecture After Intracorporal Injection of Human Placental Stem Cells in a Pelvic Neurovascular Injury Rat Model.J Sex Med2020
32806623Imaging of Fibroblast Activation Protein Alpha Expression in a Preclinical Mouse Model of Glioma Using Positron Emission Tomography.Molecules2020
30813947Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.Breast Cancer Res2019
31723594Pleural Effusion Aspirate for use in 3D Lung Cancer Modeling and Chemotherapy Screening.ACS Biomater Sci Eng2019
30813947Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.Breast Cancer Res2019
31723594Pleural Effusion Aspirate for use in 3D Lung Cancer Modeling and Chemotherapy Screening.ACS Biomater Sci Eng2019
29661830Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction.Cancer Res2018
29858793Practical Guidelines for Cerenkov Luminescence Imaging with Clinically Relevant Isotopes.Methods Mol Biol2018
30178793A comprehensively revised strategy that improves the specific activity and long-term stability of clinically relevant <sup>89</sup>Zr-immuno-PET agents.Dalton Trans2018
29661830Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction.Cancer Res2018
29858793Practical Guidelines for Cerenkov Luminescence Imaging with Clinically Relevant Isotopes.Methods Mol Biol2018
30178793A comprehensively revised strategy that improves the specific activity and long-term stability of clinically relevant <sup>89</sup>Zr-immuno-PET agents.Dalton Trans2018
28922975Bioengineered Submucosal Organoids for In Vitro Modeling of Colorectal Cancer.Tissue Eng Part A2017
28922975Bioengineered Submucosal Organoids for In Vitro Modeling of Colorectal Cancer.Tissue Eng Part A2017
28560089Characterization of a Murine Model of Bioequivalent Bladder Wound Healing and Repair Following Subtotal Cystectomy.Biores Open Access2017
28191774Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.Stem Cells Transl Med2017
28191774Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.Stem Cells Transl Med2017
28560089Characterization of a Murine Model of Bioequivalent Bladder Wound Healing and Repair Following Subtotal Cystectomy.Biores Open Access2017
26995504Near infrared fluorescent nanoparticles based on hyaluronic acid: Self-assembly, optical properties, and cell interaction.Acta Biomater2016
26995504Near infrared fluorescent nanoparticles based on hyaluronic acid: Self-assembly, optical properties, and cell interaction.Acta Biomater2016
26910374Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas.Oncotarget2016
27845768Selection of a Novel Aptamer Against Vitronectin Using Capillary Electrophoresis and Next Generation Sequencing.Mol Ther Nucleic Acids2016
27515302Tumor-associated stromal cells as key contributors to the tumor microenvironment.Breast Cancer Res2016
27877237Near Infrared Fluorescent Nanoparticles Derived from Hyaluronic Acid Improve Tumor Contrast for Image-Guided Surgery.Theranostics2016
27877237Near Infrared Fluorescent Nanoparticles Derived from Hyaluronic Acid Improve Tumor Contrast for Image-Guided Surgery.Theranostics2016
27845768Selection of a Novel Aptamer Against Vitronectin Using Capillary Electrophoresis and Next Generation Sequencing.Mol Ther Nucleic Acids2016
27515302Tumor-associated stromal cells as key contributors to the tumor microenvironment.Breast Cancer Res2016
26910374Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas.Oncotarget2016
25565445Indocyanine green-loaded nanoparticles for image-guided tumor surgery.Bioconjug Chem2015
25925380Macrophage Ablation Reduces M2-Like Populations and Jeopardizes Tumor Growth in a MAFIA-Based Glioma Model.Neoplasia2015
25565445Indocyanine green-loaded nanoparticles for image-guided tumor surgery.Bioconjug Chem2015
25966666Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway.Stem Cells2015
25925380Macrophage Ablation Reduces M2-Like Populations and Jeopardizes Tumor Growth in a MAFIA-Based Glioma Model.Neoplasia2015
25966666Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway.Stem Cells2015
24809734Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes.Oncotarget2014
25030697Lineage of origin in rhabdomyosarcoma informs pharmacological response.Genes Dev2014
  • 1 - 50 of 210

Recommended Authors

Institute of Medical Genetics and Pathology.
Career Start Year 2014
Number of shared co-authors 0
University of Minnesota, University of Minnesota Medical School
Career Start Year 2010
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 9
Robert Wood Johnson Medical School, The State University of New Jersey
Career Start Year 2007
Number of shared co-authors 2
University of California los angeles
Career Start Year 2003
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 4
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2002
Number of shared co-authors 0
University Health Network
Career Start Year 2001
Number of shared co-authors 0
Steadman Philippon Research Institute, Center for Regenerative Sports Medicine
Career Start Year 2001
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 2000
Number of shared co-authors 1
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 3
Earle A. Chiles Research Institute, Providence Cancer Institute
Career Start Year 1999
Number of shared co-authors 1
CHU Sainte-Justine Research Center
Career Start Year 1996
Number of shared co-authors 0
Oncode Institute
Career Start Year 1993
Number of shared co-authors 3
University of Toronto
Career Start Year 1991
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 1
VIB-Center for Cancer Biology
Career Start Year 1991
Number of shared co-authors 0
Heidelberg University
Career Start Year 1990
Number of shared co-authors 0
Medical College of Wisconsin
Career Start Year 1990
Number of shared co-authors 1
University of British Columbia
Career Start Year 1990
Number of shared co-authors 2
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 1
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Career Start Year 1989
Number of shared co-authors 0
Cell Therapy Institute, Paracelsus Medical University (PMU)
Career Start Year 1987
Number of shared co-authors 0
Children's Hospital at Montefiore.
Career Start Year 1986
Number of shared co-authors 7
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Advanced Research Institute, Tokyo Medical and Dental University
Career Start Year 1981
Number of shared co-authors 0
Translational and Clinical Research Institute, Newcastle University
Career Start Year 1981
Number of shared co-authors 4
Vita-Salute San Raffaele University
Career Start Year 1980
Number of shared co-authors 2
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1978
Number of shared co-authors 3
Heersink School of Medicine, The University of Alabama at Birmingham
Career Start Year 1970
Number of shared co-authors 0

Collaborators

The University of Texas M.D. Anderson Cancer Center
Co-authored papers 8
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 7
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 6
Kumamoto University Hospital
Co-authored papers 5
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Karmanos Cancer Institute (KCI), Wayne State University
Co-authored papers 4
Rutgers Cancer Institute of New Jersey
Co-authored papers 3
Rutgers Cancer Institute of New Jersey
Co-authored papers 3
CIMA-Universidad de Navarra
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
The Ohio State University Wexner Medical Center
Co-authored papers 2
UT MD Anderson Cancer Center
Co-authored papers 2
Synthego Corporation
Co-authored papers 2
Duke University
Co-authored papers 2
Co-authored papers 2
Huntsman Cancer Institute, University of Utah
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
University of Michigan Rogel Cancer Center.
Co-authored papers 1
University of Texas Health Science Center at San Antonio
Co-authored papers 1
Co-authored papers 1
Germans Trias i Pujol Research Institute
Co-authored papers 1
Co-authored papers 1
Baylor College of Medicine
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
Stanford University School of Medicine
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Stanford University School of Medicine
Co-authored papers 1
Joslin Diabetes Center
Co-authored papers 1
Weill Cornell School of Medicine
Co-authored papers 1
Houston Methodist Research Institute
Co-authored papers 1